AnuBio

Reprogramming immunomodulation using AI to cure cancer

AnuBio is a company in health & longevity based in Silicon Valley, California.

Profile

"AnuBio is a pioneering company in the fields of Artificial Intelligence, Deeptech, and Health, dedicated to reprogramming immunomodulation for cancer treatment. Utilizing phenotypic drug discovery of combinatorial biologics, AnuBio has developed a pair of groundbreaking technologies that enhance the discovery of novel immunomodulators by 100-fold. These technologies include PHENOMS, a proprietary in vitro phenotypic screening platform combined with multispecific biologics, and TRAILBLAZER AI, a revolutionary architecture AI model of the immune system. By synergizing these technologies, AnuBio has created a closed-loop lab-AI research platform that integrates real-world data and validation from PHENOMS with predictive insights from TRAILBLAZER AI. This innovative approach streamlines the drug discovery process, offering valuable predictions for success at every stage."

Its activity falls under health & longevity; the profile below is assembled from public directory data.

The company is recorded as being based in Silicon Valley, California.

The company is listed at the Plug and Play accelerated startup stage of development.

Website: anubio.ai